S&P 500   3,571.37 (+0.39%)
DOW   29,452.76 (+0.65%)
QQQ   289.76 (-0.21%)
AAPL   115.23 (-1.80%)
MSFT   209.39 (-0.48%)
FB   265.33 (-1.62%)
GOOGL   1,724.67 (-0.67%)
AMZN   3,096.12 (-0.11%)
TSLA   519.00 (+6.00%)
NVDA   524.00 (+0.09%)
BABA   267.00 (-1.38%)
CGC   23.74 (+0.08%)
GE   10.16 (+4.10%)
MU   63.66 (+3.68%)
AMD   86.31 (+1.97%)
T   28.51 (+0.67%)
NIO   51.35 (+4.26%)
F   8.95 (+2.40%)
ACB   6.98 (-2.10%)
GILD   59.91 (-0.33%)
NFLX   483.00 (-1.07%)
BA   205.64 (+3.02%)
DIS   142.36 (+0.91%)
S&P 500   3,571.37 (+0.39%)
DOW   29,452.76 (+0.65%)
QQQ   289.76 (-0.21%)
AAPL   115.23 (-1.80%)
MSFT   209.39 (-0.48%)
FB   265.33 (-1.62%)
GOOGL   1,724.67 (-0.67%)
AMZN   3,096.12 (-0.11%)
TSLA   519.00 (+6.00%)
NVDA   524.00 (+0.09%)
BABA   267.00 (-1.38%)
CGC   23.74 (+0.08%)
GE   10.16 (+4.10%)
MU   63.66 (+3.68%)
AMD   86.31 (+1.97%)
T   28.51 (+0.67%)
NIO   51.35 (+4.26%)
F   8.95 (+2.40%)
ACB   6.98 (-2.10%)
GILD   59.91 (-0.33%)
NFLX   483.00 (-1.07%)
BA   205.64 (+3.02%)
DIS   142.36 (+0.91%)
S&P 500   3,571.37 (+0.39%)
DOW   29,452.76 (+0.65%)
QQQ   289.76 (-0.21%)
AAPL   115.23 (-1.80%)
MSFT   209.39 (-0.48%)
FB   265.33 (-1.62%)
GOOGL   1,724.67 (-0.67%)
AMZN   3,096.12 (-0.11%)
TSLA   519.00 (+6.00%)
NVDA   524.00 (+0.09%)
BABA   267.00 (-1.38%)
CGC   23.74 (+0.08%)
GE   10.16 (+4.10%)
MU   63.66 (+3.68%)
AMD   86.31 (+1.97%)
T   28.51 (+0.67%)
NIO   51.35 (+4.26%)
F   8.95 (+2.40%)
ACB   6.98 (-2.10%)
GILD   59.91 (-0.33%)
NFLX   483.00 (-1.07%)
BA   205.64 (+3.02%)
DIS   142.36 (+0.91%)
S&P 500   3,571.37 (+0.39%)
DOW   29,452.76 (+0.65%)
QQQ   289.76 (-0.21%)
AAPL   115.23 (-1.80%)
MSFT   209.39 (-0.48%)
FB   265.33 (-1.62%)
GOOGL   1,724.67 (-0.67%)
AMZN   3,096.12 (-0.11%)
TSLA   519.00 (+6.00%)
NVDA   524.00 (+0.09%)
BABA   267.00 (-1.38%)
CGC   23.74 (+0.08%)
GE   10.16 (+4.10%)
MU   63.66 (+3.68%)
AMD   86.31 (+1.97%)
T   28.51 (+0.67%)
NIO   51.35 (+4.26%)
F   8.95 (+2.40%)
ACB   6.98 (-2.10%)
GILD   59.91 (-0.33%)
NFLX   483.00 (-1.07%)
BA   205.64 (+3.02%)
DIS   142.36 (+0.91%)
Log in
NASDAQ:AGIO

Agios Pharmaceuticals Earnings Date, Estimates & History

$44.49
+0.90 (+2.06 %)
(As of 11/23/2020 10:30 AM ET)
Add
Compare
Today's Range
$43.66
Now: $44.49
$44.49
50-Day Range
$33.42
MA: $38.08
$42.08
52-Week Range
$27.77
Now: $44.49
$56.74
Volume2,176 shs
Average Volume689,336 shs
Market Capitalization$3.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.85

Earnings

Agios Pharmaceuticals (NASDAQ:AGIO) Earnings Information

Agios Pharmaceuticals last released its quarterly earnings results on November 10th, 2020. The biopharmaceutical company reported ($1.43) EPS for the quarter, missing analysts' consensus estimates of ($1.36) by $0.07. The business earned $34.70 million during the quarter, compared to the consensus estimate of $38.12 million. Its quarterly revenue was up 33.5% on a year-over-year basis. Agios Pharmaceuticals has generated ($6.86) earnings per share over the last year. Agios Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 11th, 2021 based off prior year's report dates.

Agios Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Agios Pharmaceuticals (NASDAQ:AGIO) Earnings Estimates

2020 EPS Consensus Estimate: ($6.37)
2021 EPS Consensus Estimate: ($6.29)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($1.85)($1.53)($1.69)
Q2 20204($1.95)($1.55)($1.74)
Q3 20204($1.90)($0.86)($1.43)
Q4 20204($1.95)($0.91)($1.52)
Q1 20213($1.70)($1.43)($1.59)
Q2 20213($1.80)($1.42)($1.66)
Q3 20213($1.70)($1.30)($1.47)
Q4 20212($1.85)($1.28)($1.57)

Agios Pharmaceuticals (NASDAQ AGIO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/11/2021
(Estimated)
       
11/10/20209/30/2020($1.36)($1.43)($1.43)$38.12 million$34.70 millionListen
7/30/20206/30/2020($1.36)($1.31)($1.31)$37.17 million$37.30 millionTranscript
4/30/20203/31/2020($1.67)($0.59)($0.59)$31.12 million$87.10 millionTranscript
2/13/2020Q4 2019($1.72)($1.60)($1.60)$33.72 million$35.44 millionTranscript
10/31/2019Q3 2019($1.85)($1.81)($1.81)$33.13 million$26.02 millionTranscript
8/1/2019Q2 2019($1.70)($1.87)($1.87)$27.05 million$26.22 millionN/A
5/2/20193/31/2019($1.74)($1.59)($1.59)$22.69 million$30.20 millionN/A
2/14/201912/31/2018($1.65)($1.58)($1.58)$19.98 million$30.00 millionListen
11/1/20189/30/2018($1.62)($1.63)($1.63)$22.72 million$15.20 millionN/A
8/2/2018Q2 2018($1.62)($1.19)($1.19)$12.47 million$40.40 millionN/A
5/4/2018Q1 2018($1.60)($1.63)($1.63)$11.93 million$8.80 millionN/A
2/14/2018Q4 2017($1.65)($1.81)($1.81)$12.65 million$9.80 millionTranscript
11/1/2017Q3 2017($1.78)($1.59)($1.59)$10.85 million$11.35 millionN/A
8/8/2017Q2 2017($1.57)($1.78)($1.78)$10.68 million$11.30 millionListen
5/4/2017Q1 2017($1.80)($1.56)($1.56)$9.65 million$10.51 millionListen
2/16/2017Q416($1.51)($1.34)($1.34)$10.89 million$22.65 millionListen
11/3/2016Q316($1.52)($1.63)($1.63)$7.82 million$8.98 millionListen
8/4/2016Q216($0.48)($1.47)($1.47)$39.62 million$6.98 millionListen
5/5/2016Q116($0.79)($0.61)($0.61)$20.94 million$31.30 millionListen
2/18/2016Q415($0.27)($1.08)($1.08)$28.78 million$6.22 millionListen
11/5/2015Q315($0.89)($1.07)($1.07)$17.21 million$5.80 millionListen
8/6/2015Q215($0.46)($0.85)($0.85)$25.75 million$13.20 millionListen
5/7/2015Q115($0.86)($0.13)($0.13)$10.86 million$34.20 millionListen
2/17/2015Q414($0.55)($0.76)($0.76)$10.94 million$14.64 millionListen
11/7/2014Q314($0.53)$0.10$0.10$8.45 million$33.90 millionListen
8/7/2014Q2($0.47)($0.54)($0.54)$11.00 million$8.41 millionListen
5/8/2014Q1($0.37)($0.39)($0.39)$7.19 million$8.41 millionListen
3/6/2014Q4 2013($0.34)($0.40)($0.40)$6.19 million$6.70 millionListen
11/7/2013Q3 2013($0.28)($0.47)($0.47)$6.22 million$6.27 millionListen
9/5/2013Q2 2013($0.28)($2.80)($2.80)$6.19 million$6.27 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.